Viewing Stock Pick for MBP Symbol / Company MBP / METABOLIC...

Viewing Stock Pick for MBP

Symbol / Company
MBP / METABOLIC PHARMACEUTICALS LIMITED
Date Picked
30-11-2005
Price When Picked
$0.470
Company Overview
Metabolic Pharmaceuticals Limited has the mission of developing novel therapies for diseases with application to worldwide markets, including obesity, obesity-related diseases such as type 2 diabetes, and more recently, pain, and osteoporosis.

The company's operating strategy is to outsource much of its activities, minimising infrastructure and overhead costs while maximising access to world-class expertise. Contract research organisations and other contract developers are being used for all aspects of the company's pharmaceutical developments, including formulation, manufacturing, preclinical studies and clinical studies. These outsourcing activities are closely controlled by the company's management, which has the benefit of substantial skills and experience in the clinical development of drugs, the management of research and a high-level of decision-making experience in the international pharmaceutical industry.

Metabolic also has established modern laboratories at the Baker Heart Research Institute (Melbourne) for some in-house activities.


Future Earnings Per Share
Y1 Y2 Y3
0.050 0.020 0.020
(Expected dollar earnings per number of shares on issue)
Nielsen Indicator Buying Level
There has been a significant increase in buyer demand over the last couple of weeks
Weekly Trend Analysis
Downtrend
Daily Trend Analysis
Downtrend
Short Term Support
$0.445
Short Term Resistance
$0.55
Broker Analysis
Num. Analysts in Sample Recommendation
1 Strong Buy

Director Activity
Date Director Action Volume Average Price Total Consideration
30-08-2005 Roland Scollay BUY 20,000 $0.600 $12,000
24-11-2005 Patrick Sutch BUY 15,000 $0.440 $6,600
25-11-2005 Robyn Baker BUY 23,000 $0.440 $10,235

View Director Activity Chart
Graph

Top Bar - Stock Price
Bottom Bar - Nielsen Indicator